Exchange: OTC·Updated 10:30 AM EDT

INIS International Isotopes Inc.

$0.054
$0.00
(0.00%)
Today
Mkt Cap$28.57M
Vol35,000.00

About INIS

Radnostix, Inc. engages in the manufacture of nuclear medicine calibration and reference standards cobalt tele therapy sources, as well as radioisotopes and radiochemical for medical research and clinical devices. It operates through the following segments: Theranostics Products, Cobalt Products, Calibration & Reference Products, Medical Devices, and Fluorine Products. The Theranostics Products segment includes the production and distribution of various isotopically pure radiopharmaceuticals, APIs, and radiochemical for medical, industrial, and research applications. The Cobalt Products segment includes the production of various cobalt-60 products and service. The Calibration & Reference Products segment consists of various sealed source calibration and reference products, including own manufactured products, jointly manufactured products, and third-party products. The Medical Devices segment is currently under development. The Fluorine Products segment supports production and sale of various fluoride gases produced using Fluorine Extraction Process. The company was founded in November 1995 and is headquartered in Idaho Falls, ID.
50

Neutral Sentiment

How do you feel about INIS?

LifesGood
$INIS What to Consider Before You Average DownThe $13.5 Million NANO Nuclear Deal Details: Just announced, Radnostix entered a definitive agreement to divest its legacy DUF6 and fluorine assets to NANO Nuclear Energy ($NNE) for $9.5 million in cash and $4.0 million in NANO common stock. Cash Infusion vs. Market Cap: To put that in perspective, Radnostix's entire market cap has been hovering around $29 million. Securing $9.5 million in cash alongside $4 million in stock is a substantial liquidity event for a company of this size, provided the deal successfully clears regulatory hurdles (like NRC and New Mexico state approvals) over the next 90 to 120 days. Executing the Strategy: Waiting for more clarity on the closing timeline of this transaction or watching how the stock reacts as the market digests the cash injection can help you time your entries more effectively.
1

Advertisement|Remove ads.